Previous GWAS and meta-analysis studies have identified the CD6 locus (SNP rs11230563) as a susceptibility marker in CD and UC, thus supporting its contribution to IBD etiopathogenesis (35, 36). Here, CD6 is linked to inflammatory bowel disease.